New Delhi: As the world scrambles to find an medicine or vaccine against the Covid-19, Indian companies seem to be making substantial progress in vaccine development.

PM Modi on Tuesday chaired a meeting of the task force on Coronavirus vaccine development, to review status of India’s progress in vaccine development, drug discovery, diagnosis and testing.

According to a statement released by Prime Minister’s Office (PMO), “Indian vaccine companies have come across as innovators in early stage vaccine development research. Similarly, Indian academia and start-ups have also pioneered in this area. Over 30 Indian vaccines are in different stages of vaccine development, with few going on to trial stages.”

Indian vaccine companies have come across as innovators in early stage vaccine development research.Similarly,Indian academia&start-ups have also pioneered in this area. Over 30 Indian vaccines are in different stages of vaccine development,with few going on to trial stages: PMO https://t.co/mBJ9r5teuQ

— ANI (@ANI) May 5, 2020

“In diagnosis and testing, several academic research institutions and start-ups have developed new tests, both for the RT-PCR approach and for the antibody detection. In addition, by linking laboratories all over the country, capacity for both these kinds of tests have been enormously scaled up. The problem of importing reagents for testing has been addressed by consortia of Indian start-ups and industry, meeting current requirements. The current thrust also holds promise for the development of a robust long-term industry in this area,” the PMO said in the statement.